Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution
Status:
Completed
Trial end date:
2021-10-29
Target enrollment:
Participant gender:
Summary
This is a randomised, open-label, 3-period, crossover single dose study to assess the
relative bioavailability of two formulations of HTL0016878: an oral solution of HCl salt form
(the reference product) and an oral capsule containing citrate salt (the test product); and
of the effect of food on the pharmacokinetics of the capsule formulation.